Intranasal Dexmedetomidine Administration Precipitates Respiratory Failure in Child With Croup and Asthma
Intranasal dexmedetomidine administration in clinically recommended doses has a small but important risk of causing catastrophic respiratory failure in the setting of preexisting severe respiratory workloads.
Authors
- William E. Novotny (ORCID: https://orcid.org/0000-0001-7010-0590)
- Pam Fox
- Dynita Haislip
Institutions
- Prisma Health (US)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/ccr3.9602
- Citations
- 2
- Primary Topic
- Airway Management and Intubation Techniques
- Type
- article
- Field-Weighted Citation Impact
- 1.28